Integrating Typhoid Fever Within the Sustainable Development Goals: Pragmatism or Utopia?


Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
15 02 2019
Historique:
entrez: 16 2 2019
pubmed: 16 2 2019
medline: 30 1 2020
Statut: ppublish

Résumé

Several decades following the first estimates of the global burden of typhoidal salmonellosis (infections caused by Salmonella Typhi and Salmonella Paratyphi), this disorder remains a major cause of morbidity worldwide with an estimated 17 million cases annually. The risk factors for typhoid include poverty, poor living conditions with unsafe water and lack of adequate sanitation, and unsafe foods-all reasons for the disease burden being highest among such populations including urban slums. A recent review of typhoid trends globally and in specific countries suggests that the relative contributions of these risk factors to disease burden reduction as well as persistence have varied. There is also the risk of periodic outbreaks related to introduction of relatively virulent drug-resistant strains or movements of vulnerable populations, including those in conflict zones. Most countries of the world are now aligning their health and multisectoral strategies to address the Sustainable Development Goals (SDGs) and targets, which were agreed upon by all countries of the world in September 2015. Though neglected so far, there are huge opportunities for mainstreaming typhoid prevention and control strategies within the SDGs. This article reviews some of the approaches that may help elevate typhoid to a higher level of awareness in public health programs and policy and to ensure that investments in major public health preventive measures are made part of the universal health coverage agenda.

Identifiants

pubmed: 30767006
pii: 5320190
doi: 10.1093/cid/ciy957
pmc: PMC6376087
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

S34-S41

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America.

Références

Am J Trop Med Hyg. 2018 Sep;99(3_Suppl):89-96
pubmed: 30047361
World J Gastroenterol. 2017 Mar 21;23(11):1925-1931
pubmed: 28373758
Trop Med Int Health. 2009 Jun;14(6):696-702
pubmed: 19392739
Am J Trop Med Hyg. 2018 Sep;99(3_Suppl):79-88
pubmed: 30047365
PLoS Negl Trop Dis. 2017 Feb 27;11(2):e0005376
pubmed: 28241011
mBio. 2018 Feb 20;9(1):
pubmed: 29463654
Lancet. 2017 Dec 2;390(10111):2472-2480
pubmed: 28965718
Epidemiol Infect. 2006 Jun;134(3):612-6
pubmed: 16288686
Lancet. 2017 Sep 16;390(10100):1423-1459
pubmed: 28916366
Vaccine. 2019 Jan 7;37(2):214-216
pubmed: 29661581
Trop Med Int Health. 2001 Jun;6(6):484-90
pubmed: 11422963
J Glob Health. 2012 Jun;2(1):010401
pubmed: 23198130
PLoS One. 2016 Jun 09;11(6):e0155286
pubmed: 27281311
N Engl J Med. 2018 Oct 18;379(16):1493-1495
pubmed: 30332569
Bull World Health Organ. 2004 May;82(5):346-53
pubmed: 15298225
Lancet Glob Health. 2017 Mar;5(3):e310-e323
pubmed: 28193398
BMC Public Health. 2007 Oct 12;7:289
pubmed: 17935611
BMC Public Health. 2017 Jan 5;17(1):23
pubmed: 28056940
Epidemiol Infect. 2012 Apr;140(4):665-72
pubmed: 21676350
BMJ. 2018 Jan 23;360:k125
pubmed: 29363500
Trans R Soc Trop Med Hyg. 2005 Jun;99(6):440-50
pubmed: 15837356
Epidemiol Infect. 2007 Apr;135(3):458-65
pubmed: 16893490
Clin Infect Dis. 2012 Apr;54(8):1107-9
pubmed: 22357701
J Health Popul Nutr. 2004 Sep;22(3):311-21
pubmed: 15609784
Cochrane Database Syst Rev. 2014 Jan 02;(1):CD001261
pubmed: 24385413
Trop Med Int Health. 2007 Jul;12(7):838-47
pubmed: 17596250
Clin Infect Dis. 2017 Jun 1;64(11):1604-1611
pubmed: 28369224
BMC Public Health. 2009 Apr 27;9:115
pubmed: 19397806
Clin Microbiol Rev. 2015 Oct;28(4):901-37
pubmed: 26180063
Trans R Soc Trop Med Hyg. 2005 Nov;99(11):819-26
pubmed: 16099488
Am J Trop Med Hyg. 2018 Sep;99(3_Suppl):10-19
pubmed: 30047364

Auteurs

Zulfiqar A Bhutta (ZA)

Centre for Global Child Health, The Hospital for Sick Children, Toronto, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH